Fotagliptin add‐on therapy to metformin in patients with uncontrolled type 2 diabetes: A randomised, multicentre, double‐blind, placebo‐controlled, phase 3 trial
In patients with T2D who experienced inadequate glycaemic control with metformin, fotagliptin achieved a superior and clinically meaningful improvement in glycaemic control compared with placebo.
Authors
- Nan Yu
- Chaoli Yan
- G H Li
- Xiaosong Shu (ORCID: https://orcid.org/0009-0007-5533-1463)
- Wei Zhang (ORCID: https://orcid.org/0000-0002-6885-5166)
- Xiaohui Guo (ORCID: https://orcid.org/0000-0002-5588-0995)
- Yawei Zhang (ORCID: https://orcid.org/0000-0002-0571-8383)
- Wenjie Xu
- Mingtong Xu
- Shuguang Pang (ORCID: https://orcid.org/0000-0002-8331-6590)
- Wei‐Xia Peng (ORCID: https://orcid.org/0000-0003-0675-3794)
- Dongmei Zhou (ORCID: https://orcid.org/0000-0003-0163-8164)
- Xin Zhang (ORCID: https://orcid.org/0000-0001-6388-9327)
Institutions
- Sun Yat-sen University (CN)
- Xuzhou Medical College (CN)
- Peking University (CN)
- Sun Yat-sen Memorial Hospital (CN)
- Cangzhou Central Hospital (CN)
- Daqing Oilfield General Hospital (CN)
- Jiangxi Pingxiang People's Hospital (CN)
- Peking University First Hospital (CN)
- Shandong First Medical University (CN)
- Inner Mongolia Medical University (CN)
- Qiqihar Medical University (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2025-04-30
- DOI
- https://doi.org/10.1111/dom.16427
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00